Indian Boards Database

PRESENT BOARD OF DIRECTORS As last updated by the Company/Indian Boards on 07-AUG-2026

Sl.No.	Director Name	Position on the Board
1.	KIRAN MAZUMDAR SHAW (DR.(MS.))	CHAIRPERSON, EXECUTIVE DIRECTOR, PROMOTER-DIRECTOR
2.	SHREEHAS PRADEEP TAMBE (MR.)	MANAGING DIRECTOR, EXECUTIVE DIRECTOR

3.	DANIEL MARK BRADBURY (MR.)
4.	ARUN SURESH CHANDAVARKAR (DR.(MR.))
5.	ATUL DHAWAN (MR.)
6.	NAINA LAL KIDWAI (MS.)
7.	RAJIV MALIK (MR.)
8.	ERIC VIVEK MAZUMDAR (DR.(MR.))
9.	RAVI RASENDRA MAZUMDAR (PROF.(DR.(MR.)))
10.	REKHA MEHROTRA MENON (MS.)
11.	PETER BARON PIOT (MR.)
12.	NIVRUTI RAI (MS.)
13.	THOMAS JASON ROBERTS (MR.)

Note:

The information shown above is as provided by the company/updated by us.
There could be a time lag between the date of company filing information/correction with us and the same getting reflected on this website, mainly because of the processes involved as also the need for data verification/cleaning.
Tenure of directors has been captured from announcements starting from 01-Aug-2017 onwards.
Data for a company prior to its listing on NSE is not available.
Data for Companies exclusively listed on BSE with market capitalization more than Rs. 1000 crore is available from 1st April 2019 onwards.
In case you notice any discrepancies with the data, you are requested to let us know immediately so that we can take appropriate action.

COMMITTEES

1.	AUDIT COMMITTEE
2.	CORPORATE SOCIAL RESPONSIBILITY & ESG COMMITTEE
3.	FUND RAISING COMMITTEE
4.	NOMINATION & REMUNERATION COMMITTEE
5.	RISK MANAGEMENT COMMITTEE
6.	STAKEHOLDERS/INVESTORS RELATIONSHIP COMMITTEE

Note:

The information shown above is as provided by the company/updated by us.
There could be a time lag between the date of company filing information/correction with us and the same getting reflected on this website, mainly because of the processes involved as also the need for data verification/cleaning.
Data for a company prior to its listing on NSE is not available.
Committee details is available from 2015-16 onwards.
Data for Companies exclusively listed on BSE with market capitalization more than Rs. 1000 crore is available from 1st April 2019 onwards.
In case you notice any discrepancies with the data, you are requested to let us know immediately so that we can take appropriate action.

REMUNERATION OF DIRECTORS

EXECUTIVE DIRECTORS (Rs.lacs)

Director Name	Position on the Board	First Date of Appointment	2025-26	2024-25	2023-24	2022-23	2021-22	2020-21	2019-20	2018-19	2017-18	2016-17	2015-16	2014-15	2013-14	2012-13	2011-12	2010-11	2009-10
KIRAN MAZUMDAR SHAW (DR.(MS.))	CHAIRPERSON, EXECUTIVE DIRECTOR, PROMOTER-DIRECTOR	29 NOV 1978	549.60	871.60	384.30	300.00	246.00	406.00	392.50	280.90	226.60	204.10	160.20	155.20	163.47	153.21	150.50	144.08	141.40
SIDDHARTH MITTAL (MR.)	MANAGING DIRECTOR, EXECUTIVE DIRECTOR	01 DEC 2019	2,228.30	737.10	573.10	478.80	422.00	430.00	95.60	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.

NON-EXECUTIVE DIRECTORS (Rs.lacs)

Director Name	Position on the Board	First Date of Appointment	2025-26	2024-25	2023-24	2022-23	2021-22	2020-21	2019-20	2018-19	2017-18	2016-17	2015-16	2014-15	2013-14	2012-13	2011-12	2010-11	2009-10
JOHN MCCALLUM MARSHALL SHAW (MR.)	VICE CHAIRPERSON, NON-EXECUTIVE DIRECTOR	12 JAN 1998	N.A.	N.A.	N.A.	N.A.	9.30	21.20	20.70	15.50	63.90	172.30	156.30	147.80	122.06	101.58	95.23	72.91	80.72
NEVILLE CLIFFORD BAIN (LATE DR.(MR.))	NON-EXECUTIVE DIRECTOR	08 AUG 2000	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	0.00	11.80	11.35	1.35
PETER JOHN JONATHAN BAINS (MR.)	NON-EXECUTIVE DIRECTOR	12 DEC 2022	N.A.	N.A.	19.10	32.80	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.
DANIEL MARK BRADBURY (MR.)	NON-EXECUTIVE DIRECTOR	25 APR 2013	0.00	**	**	17.20	66.70	31.90	27.30	39.90	34.60	26.10	27.10	30.60	14.28	N.A.	N.A.	N.A.	N.A.
ARUN SURESH CHANDAVARKAR (DR.(MR.))	NON-EXECUTIVE DIRECTOR	24 APR 2014	0.00	**	**	**	**	**	540.80	382.70	376.00	363.00	348.50	265.70	N.A.	N.A.	N.A.	N.A.	N.A.
CHARLES LELAND COONEY (PROF.(MR.))	NON-EXECUTIVE DIRECTOR	19 JAN 2001	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	36.30	20.70	11.35	11.80	11.80	1.80
MELEVEETIL DAMODARAN (MR.)	NON-EXECUTIVE DIRECTOR	26 APR 2016	N.A.	1.70	63.20	59.90	57.60	31.90	27.30	26.30	24.60	23.50	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.
ATUL DHAWAN (MR.)	NON-EXECUTIVE DIRECTOR	16 MAY 2024	74.00	66.30	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.
NICHOLAS ROBERT HAGGAR (MR.)	NON-EXECUTIVE DIRECTOR	01 SEP 2023	80.50	75.60	52.00	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.
MARY HARNEY (MS.)	NON-EXECUTIVE DIRECTOR	26 APR 2012	N.A.	N.A.	N.A.	14.10	55.00	31.90	39.70	41.40	36.50	32.10	29.60	27.60	13.30	8.30	N.A.	N.A.	N.A.
LEVIN M.JEREMY (DR.(MR.))	NON-EXECUTIVE DIRECTOR	22 JAN 2015	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	29.80	34.40	26.20	36.20	31.00	17.10	N.A.	N.A.	N.A.	N.A.	N.A.
NAINA LAL KIDWAI (MS.)	NON-EXECUTIVE DIRECTOR	28 APR 2022	102.10	68.00	62.40	64.80	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.
VIJAY KUMAR KUCHROO (DR.(MR.))	NON-EXECUTIVE DIRECTOR	22 JAN 2015	N.A.	N.A.	0.80	54.00	48.00	27.10	26.70	39.10	15.40	24.40	22.90	13.90	N.A.	N.A.	N.A.	N.A.	N.A.
BALA S.MANIAN (DR.(MR.))	NON-EXECUTIVE DIRECTOR	20 OCT 2004	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	21.10	13.10	10.60	10.80	10.80	0.80
ERIC VIVEK MAZUMDAR (DR.(MR.))	NON-EXECUTIVE DIRECTOR	01 NOV 2021	66.80	59.50	55.70	52.70	25.20	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.
RAVI RASENDRA MAZUMDAR (PROF.(DR.(MR.)))	NON-EXECUTIVE DIRECTOR, PROMOTER-DIRECTOR	08 AUG 2000	79.00	68.00	62.30	58.70	53.20	30.30	36.50	35.10	4.00	4.00	5.00	4.00	1.60	0.80	0.60	0.60	0.60
REKHA MEHROTRA MENON (MS.)	NON-EXECUTIVE DIRECTOR	26 JUL 2023	79.90	66.30	57.00	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.
BOBBY KANU PARIKH (MR.)	NON-EXECUTIVE DIRECTOR	27 JUL 2018	91.30	83.30	78.10	74.30	71.20	41.70	38.40	22.60	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.
SURESH NARSAPPA TALWAR (MR.)	NON-EXECUTIVE DIRECTOR	17 MAY 2003	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	23.90	14.90	11.35	11.60	11.60	1.60
JOHN RUSSELL FOTHERINGHAM WALLS (MR.)	NON-EXECUTIVE DIRECTOR	28 APR 2011	N.A.	N.A.	N.A.	N.A.	N.A.	N.A.	11.60	48.20	44.20	41.50	40.60	38.80	25.70	11.80	11.10	N.A.	N.A.

View Remuneration Break-Up

Note:

The information shown above is as provided by the company/updated by us.
There could be a time lag between the date of company filing information/correction with us and the same getting reflected on this website, mainly because of the processes involved as also the need for data verification/cleaning.
Remuneration data is available from 2009-10 onwards.
For standardizing the remuneration data across different financial years/accounting periods of companies, remuneration figures for years other than an 'April-March' Financial Year have been adjusted on a pro-rata basis. For e.g. remuneration for calendar year 2020 (viz. January-December 2020) has been taken 3 months into 2019-20 and 9 months into 2020-21.
Bonus/Commission/Variable Pay is added in the year to which it pertains and not the year in which it is paid out.
Stock Options/Shares Held figures at any date other than 31st March have been reflected as the holding on the end date of the financial year in which that date is falling. For e.g. Stock Options/Shares Held figures on 31st December 2019 shall reflect as Stock Options/Shares Held figures on 31st March 2020.
In case sitting fee is revised mid-year and neither the total amount paid as sitting fee to a particular director nor director-wise date-wise board meetings attended has been specified, the total number of board meetings held during the year have been pro-rated on the basis of the date of revision of the sitting fee.

**Data presently under compilation

Ratio to Median Remuneration has been captured from 2016-17 onwards.
Professional Fee is available from FY 2016-17 onwards.
Data for a company prior to its listing on NSE is not available.
Data for Companies exclusively listed on BSE with market capitalization more than Rs. 1000 crore is available from 1st April 2019 onwards.
In case you notice any discrepancies with the data, you are requested to let us know immediately so that we can take appropriate action.

CESSATION OF DIRECTORS

Sl.No.	Director Name	Last Held Position on the Board	Independent Director	First Date of Appointment as a Director	Date of Cessation	Reason of Cessation
NON-INDEPENDENT DIRECTOR CESSATIONS
1.	SIDDHARTH MITTAL (MR.)	MANAGING DIRECTOR, EXECUTIVE DIRECTOR Click here to view past changes in Position on the Board	NO	01-DEC-2019 Click here to view subsequent re-appointment/cessation dates	31-MAR-2026	RESIGNED (DUE TO CHANGE IN ROLE)Click here to view verbatim text of reason for cessation
2.	JOHN MCCALLUM MARSHALL SHAW (MR.)	VICE CHAIRPERSON, NON-EXECUTIVE DIRECTOR	NO	12-JAN-1998 Click here to view subsequent re-appointment/cessation dates	23-JUL-2021	RESIGNED (DUE TO HEALTH REASONS)
INDEPENDENT DIRECTOR CESSATIONS
3.	NICHOLAS ROBERT HAGGAR (MR.)	NON-EXECUTIVE DIRECTOR	YES	01-SEP-2023	06-AUG-2026	TERM EXPIRED Click here to view verbatim text of reason for cessation
4.	BOBBY KANU PARIKH (MR.)	NON-EXECUTIVE DIRECTOR	YES	27-JUL-2018 Click here to view subsequent re-appointment/cessation dates	22-JUL-2026	TERM EXPIRED Click here to view verbatim text of reason for cessation
5.	MELEVEETIL DAMODARAN (MR.)	NON-EXECUTIVE DIRECTOR	YES	26-APR-2016 Click here to view subsequent re-appointment/cessation dates	25-JUL-2024	RETIRED/SUPERANNUATED/TERM EXPIRED Click here to view verbatim text of reason for cessation
6.	PETER JOHN JONATHAN BAINS (MR.)	NON-EXECUTIVE DIRECTOR	YES	12-DEC-2022	18-SEP-2023	RESIGNED (DUE TO CHANGE IN ROLE)Click here to view verbatim text of reason for cessation
7.	VIJAY KUMAR KUCHROO (DR.(MR.))	NON-EXECUTIVE DIRECTOR	YES	22-JAN-2015 Click here to view subsequent re-appointment/cessation dates	26-JUL-2023	RETIRED/SUPERANNUATED/TERM EXPIRED Click here to view verbatim text of reason for cessation
8.	MARY HARNEY (MS.)	NON-EXECUTIVE DIRECTOR	YES	26-APR-2012	27-JUL-2022	RETIRED/SUPERANNUATED/TERM EXPIRED
9.	LEVIN M.JEREMY (DR.(MR.))	NON-EXECUTIVE DIRECTOR	YES	22-JAN-2015 Click here to view subsequent re-appointment/cessation dates	23-JAN-2020	RESIGNED (DUE TO RELOCATION OUTSIDE INDIA)
10.	JOHN RUSSELL FOTHERINGHAM WALLS (MR.)	NON-EXECUTIVE DIRECTOR	YES	28-APR-2011 Click here to view subsequent re-appointment/cessation dates	26-JUL-2019	RETIRED/SUPERANNUATED/TERM EXPIRED
11.	SURESH NARSAPPA TALWAR (MR.)	NON-EXECUTIVE DIRECTOR	YES	17-MAY-2003	25-JUL-2014
12.	BALA S.MANIAN (DR.(MR.))	NON-EXECUTIVE DIRECTOR	YES	20-OCT-2004	25-JUL-2014
13.	CHARLES LELAND COONEY (PROF.(MR.))	NON-EXECUTIVE DIRECTOR	YES	19-JAN-2001	25-JUL-2014
14.	NEVILLE CLIFFORD BAIN (LATE DR.(MR.))	NON-EXECUTIVE DIRECTOR	YES	08-AUG-2000	22-MAY-2012	DEMISE

Note:

The information shown above is as provided by the company/updated by us.
There could be a time lag between the date of company filing information/correction with us and the same getting reflected on this website, mainly because of the processes involved as also the need for data verification/cleaning.
Cessations data is from 1 January 2006 onwards.
Data for a company prior to its listing on NSE is not available.
Data for Companies exclusively listed on BSE with market capitalization more than Rs. 1000 crore is available from 1st April 2019 onwards.
In case you notice any discrepancies with the data, you are requested to let us know immediately so that we can take appropriate action.

ATTENDANCE

2024-25 2023-24 2022-23 2021-22 2020-21 2019-20 2018-19 2017-18 2016-17 2015-16 2014-15

EXECUTIVE DIRECTORS

Director Name	Position on the Board	Independent Director	2025-26 (Total No. of Board Meetings held : 12)
Director Name	Position on the Board	Independent Director	Total No. of Board Meetings held during the Tenure of Director	No. of Board Meetings Attended	% Attendance
KIRAN MAZUMDAR SHAW (DR.(MS.))	CHAIRPERSON, EXECUTIVE DIRECTOR, PROMOTER-DIRECTOR	NO	12	12	100.00
SIDDHARTH MITTAL (MR.)	MANAGING DIRECTOR, EXECUTIVE DIRECTOR	NO	12	12	100.00

NON-EXECUTIVE DIRECTORS

Director Name	Position on the Board	Independent Director	2025-26 (Total No. of Board Meetings Held : )
Director Name	Position on the Board	Independent Director	Total No. of Board Meetings held during the Tenure of Director	No. of Board Meetings Attended	% Attendance
ARUN SURESH CHANDAVARKAR (DR.(MR.))	NON-EXECUTIVE DIRECTOR	YES	N.A.		N.A.
ATUL DHAWAN (MR.)	NON-EXECUTIVE DIRECTOR	YES	12	11	91.67
NICHOLAS ROBERT HAGGAR (MR.)	NON-EXECUTIVE DIRECTOR	YES	12	10	83.33
NAINA LAL KIDWAI (MS.)	NON-EXECUTIVE DIRECTOR	YES	12	12	100.00
ERIC VIVEK MAZUMDAR (DR.(MR.))	NON-EXECUTIVE DIRECTOR	NO	12	11	91.67
RAVI RASENDRA MAZUMDAR (PROF.(DR.(MR.)))	NON-EXECUTIVE DIRECTOR, PROMOTER-DIRECTOR	NO	12	12	100.00
REKHA MEHROTRA MENON (MS.)	NON-EXECUTIVE DIRECTOR	YES	12	12	100.00
BOBBY KANU PARIKH (MR.)	NON-EXECUTIVE DIRECTOR	YES	12	12	100.00

Note:

The information shown above is as provided by the company/updated by us.
There could be a time lag between the date of company filing information/correction with us and the same getting reflected on this website, mainly because of the processes involved as also the need for data verification/cleaning.
Board Meeting Attendance data is available from 2014-15 onwards.
Data for a company prior to its listing on NSE is not available.
Data for Companies exclusively listed on BSE with market capitalization more than Rs. 1000 crore is available from 1st April 2019 onwards.
In case you notice any discrepancies with the data, you are requested to let us know immediately so that we can take appropriate action.

BOARD EVALUATION DETAILS
2025-26

2016-17 2017-18 2018-19 2019-20 2020-21 2021-22 2022-23 2023-24 2024-25

ONE OF THE KEY FUNCTIONS OF THE BOARD IS TO MONITOR AND REVIEW THE BOARD EVALUATION FRAMEWORK. THE NOMINATION AND REMUNERATION COMMITTEE IN CONSULTATION WITH THE BOARD, LAID DOWN THE EVALUATION CRITERIA FOR THE PERFORMANCE OF THE CHAIRPERSON, BOARD, COMMITTEES OF THE BOARD, AND EXECUTIVE/ NON-EXECUTIVE/ INDEPENDENT DIRECTORS THROUGH PEER EVALUATION, EXCLUDING THE DIRECTOR BEING EVALUATED, WHICH INCLUDES THE FOLLOWING: THE BOARD: COMPOSITION, QUALITY & CULTURE, AGENDA, DYNAMICS, STRATEGY, BUSINESS PERFORMANCE, SUCCESSION PLANNING, RISK MANAGEMENT, BOARD AND MANAGEMENT RELATIONS, CONTINUOUS IMPROVEMENT, AMONG OTHERS. THE COMMITTEES: COMPOSITION, PROCESS & DYNAMICS, EFFECTIVENESS, STRUCTURE, MEETINGS, INDEPENDENCE OF THE COMMITTEE, CONTRIBUTION TO DECISION MAKING OF THE BOARD, AMONG OTHERS. INDIVIDUAL DIRECTORS (INCLUDING CHAIRPERSON, MANAGING DIRECTOR, INDEPENDENT DIRECTORS AND NON-INDEPENDENT DIRECTORS): QUALIFICATION & EXPERIENCE, LEADERSHIP, GOVERNANCE, COMMITMENT, CONTRIBUTION, EXPERTISE, INDEPENDENCE, INTEGRITY, ATTENDANCE, RESPONSIBILITY, AMONG OTHERS. FURTHER, THE BOARD HAD AGREED TO UNDERTAKE THE BOARD EVALUATION BY AN EXTERNAL AGENCY, AT LEAST ONCE IN A BLOCK OF EVERY 3 (THREE) FINANCIAL YEARS. FOR FY 2025-26, THE BOARD HAD UNDERTAKEN THE PERFORMANCE EVALUATION EXERCISE THROUGH SELF EVALUATION QUESTIONNAIRES. THESE QUESTIONNAIRES FOCUSED ON CRITICAL ASPECTS SUCH AS BOARD COMPOSITION, BOARD DYNAMICS, EXECUTION AND PERFORMANCE OF SPECIFIC DUTIES AMONGST OTHER KEY CRITERIA. THE FEEDBACK-CUM-ASSESSMENT OF INDIVIDUAL DIRECTORS, THE BOARD AND ITS COMMITTEES, WERE COMPILED AND THE PERFORMANCE EVALUATION REPORT WAS DISCUSSED BY INDEPENDENT DIRECTORS AND THE BOARD / COMMITTEES. IN ORDER TO FURTHER UPHOLD THE EFFECTIVENESS OF THE BOARD’S GOVERNANCE, AN OVERVIEW OF THE SUGGESTIONS AS DRAWN FROM THE EVALUATION EXERCISE WAS DELIBERATED AND RECOMMENDED FOR IMPLEMENTATION IN DUE COURSE OF TIME. THE OUTCOME OF THE PERFORMANCE EVALUATION PROCESS FOR FY 2025-26 AND THE ACTIONS THEREON ARE SUMMARISED BELOW: THE BIOCON BOARD HAS EXHIBITED A STRONG SENSE OF FIDUCIARY AND GOVERNANCE RESPONSIBILITY AND HAS HELPED THE COMPANY NAVIGATE FINANCIAL AND PERFORMANCE SEASONALITY. OVERALL, BOARD MEMBERS ARE POSITIVE ABOUT BOARD FUNCTIONING, WITH PROGRESSIVE CHANGES IMPLEMENTED SINCE THE LAST EXTERNAL REVIEW OF THE BOARD. TRUST AND MUTUAL RESPECT ARE EVIDENT BETWEEN BOARD MEMBERS AND BETWEEN BOARD AND MANAGEMENT. THE CHAIR LEADS WITH INFORMED VIEWS AND OPENNESS TO DIVERSE PERSPECTIVES. THE BOARD’S BALANCED AND DIVERSE COMPOSITION CONTINUES TO OFFER VALUABLE GUIDANCE, AND ITS COMMITTEES REMAIN EFFECTIVE IN TERMS OF ITS COMPOSITION, FUNCTIONING AND CONTRIBUTIONS.KEY RECOMMENDATIONS OUT OF THE EVALUATION EXERCISE INCLUDE, INTER ALIA, MORE FOCUS OF THE BOARD ON INTEGRATION BENEFITS, GROWTH STRATEGY, CAPITAL EFFICIENCY, AND SUSTAINED FINANCIAL PERFORMANCE, WHILE ALSO STRENGTHENING OVERSIGHT OF LEADERSHIP TRANSITION, SUCCESSION, ORGANISATIONAL DESIGN, INTEGRATION-RELATED CHANGE MANAGEMENT, AND CYBER CONTROLS; AND ENSURING CONTINUOUS BOARD UPSKILLING ON GOVERNANCE, EMERGING RISKS, AND INDUSTRY TRENDS. IN RESPONSE TO THE SUGGESTIONS IN THE PREVIOUS BOARD EVALUATION PROCESS APPROPRIATE STEPS WERE INITIATED / UNDERTAKEN TO ADDRESS THE KEY AREAS IDENTIFIED THROUGH THE EVALUATION EXERCISE WHICH INCLUDE, INTER ALIA, FOSTERING CROSS-LEARNING ACROSS GROUP COMPANIES, WITH THE OBJECTIVE OF FACILITATING EXCHANGE OF RELEVANT PRACTICES AND STRENGTHENING ALIGNMENT ON COMMON PRIORITIES; EFFORTS ARE BEING MADE TO ENHANCE ENGAGEMENT BETWEEN THE BOARD AND THE EXECUTIVE LEADERSHIP TEAM THROUGH MORE FOCUSED INTERACTIONS, THEREBY ENABLING DEEPER STRATEGIC DIALOGUE AND IMPROVED VISIBILITY INTO BUSINESS PRIORITIES AND EXECUTION MATTERS; STEPS ARE BEING TAKEN TO ENRICH BOARD DISCUSSIONS THROUGH THE INCLUSION OF RELEVANT INDUSTRY AND MARKET INSIGHTS. IN ADDITION, TALENT MANAGEMENT AND SUCCESSION PLANNING REMAIN IMPORTANT AREAS OF FOCUS. THE BOARD INTENDS TO PROVIDE MORE FOCUS ON LEADERSHIP PIPELINE, CRITICAL ROLE READINESS AND C-SUITE SUCCESSION TO ENSURE LONG-TERM ORGANIZATIONAL RESILIENCE AND CONTINUITY.

Note:

The information shown above is as provided by the company/updated by us.
There could be a time lag between the date of company filing information/correction with us and the same getting reflected on this website, mainly because of the processes involved as also the need for data verification/cleaning.
Board evaluation details have been captured as disclosed by the companies. No editing/error correction has been done.
Data for a company prior to its listing on NSE is not available.
Data for Companies exclusively listed on BSE with market capitalization more than Rs. 1000 crore is available from 1st April 2019 onwards.
In case you notice any discrepancies with the data, you are requested to let us know immediately so that we can take appropriate action.

SKILLS/COMPETENCIES

Sl.No.	Director Name	Skills/Competencies
1.	KIRAN MAZUMDAR SHAW (DR.(MS.))	ACCOUNTS/AUDIT/TAXATION CORPORATE GOVERNANCE FINANCE HEALTHCARE INFORMATION TECHNOLOGY INTERNATIONAL BUSINESS LEADERSHIP/MANAGEMENT LEGAL/COMPLIANCE OPERATIONS RESEARCH & DEVELOPMENT RISK MANAGEMENT STRATEGY
2.	DANIEL MARK BRADBURY (MR.)	CORPORATE GOVERNANCE CORPORATE SOCIAL RESPONSIBILITY FINANCE LEADERSHIP/MANAGEMENT LEGAL/COMPLIANCE RESEARCH & DEVELOPMENT RISK MANAGEMENT
3.	ATUL DHAWAN (MR.)	ACCOUNTS/AUDIT/TAXATION FINANCE LEADERSHIP/MANAGEMENT RISK MANAGEMENT STRATEGY
4.	NAINA LAL KIDWAI (MS.)	ACCOUNTS/AUDIT/TAXATION CORPORATE GOVERNANCE CORPORATE SOCIAL RESPONSIBILITY FINANCE HEALTHCARE HUMAN RESOURCES INTERNATIONAL BUSINESS LEADERSHIP/MANAGEMENT LEGAL/COMPLIANCE RESEARCH & DEVELOPMENT RISK MANAGEMENT STRATEGY
5.	ERIC VIVEK MAZUMDAR (DR.(MR.))	FINANCE INFORMATION TECHNOLOGY RESEARCH & DEVELOPMENT RISK MANAGEMENT
6.	RAVI RASENDRA MAZUMDAR (PROF.(DR.(MR.)))	ACCOUNTS/AUDIT/TAXATION CORPORATE SOCIAL RESPONSIBILITY FINANCE HUMAN RESOURCES INFORMATION TECHNOLOGY LEADERSHIP/MANAGEMENT OPERATIONS RESEARCH & DEVELOPMENT RISK MANAGEMENT STRATEGY
7.	REKHA MEHROTRA MENON (MS.)	ACCOUNTS/AUDIT/TAXATION CORPORATE GOVERNANCE CORPORATE SOCIAL RESPONSIBILITY FINANCE HUMAN RESOURCES INFORMATION TECHNOLOGY INTERNATIONAL BUSINESS LEADERSHIP/MANAGEMENT LEGAL/COMPLIANCE RISK MANAGEMENT STRATEGY

Note:

The information shown above is as provided by the company/updated by us.
There could be a time lag between the date of company filing information/correction with us and the same getting reflected on this website, mainly because of the processes involved as also the need for data verification/cleaning.
Skills/Competencies of directors are disclosed by companies in their Annual Reports. We have further standardised and uniqued the same.
Data for a company prior to its listing on NSE is not available.
Data for Companies exclusively listed on BSE with market capitalization more than Rs. 1000 crore is available from 1st April 2019 onwards.
In case you notice any discrepancies with the data, you are requested to let us know immediately so that we can take appropriate action.

Co-sponsors of
THE PRIME DIRECTORY

Indian Boards Database

BIOCON LTD.

PRESENT BOARD OF DIRECTORS As last updated by the Company/Indian Boards on 07-AUG-2026

COMMITTEES

REMUNERATION OF DIRECTORS

EXECUTIVE DIRECTORS (Rs.lacs)

NON-EXECUTIVE DIRECTORS (Rs.lacs)

CESSATION OF DIRECTORS

NON-INDEPENDENT DIRECTOR CESSATIONS

INDEPENDENT DIRECTOR CESSATIONS

ATTENDANCE

EXECUTIVE DIRECTORS

NON-EXECUTIVE DIRECTORS

BOARD EVALUATION DETAILS
2025-26

SKILLS/COMPETENCIES

To view more data, you need to register with us.

Not a member yet? Join

Change Password

Indian Boards Database

BIOCON LTD.

PRESENT BOARD OF DIRECTORS As last updated by the Company/Indian Boards on 07-AUG-2026

COMMITTEES

REMUNERATION OF DIRECTORS

EXECUTIVE DIRECTORS (Rs.lacs)

NON-EXECUTIVE DIRECTORS (Rs.lacs)

CESSATION OF DIRECTORS

NON-INDEPENDENT DIRECTOR CESSATIONS

INDEPENDENT DIRECTOR CESSATIONS

ATTENDANCE

EXECUTIVE DIRECTORS

NON-EXECUTIVE DIRECTORS

BOARD EVALUATION DETAILS 2025-26

SKILLS/COMPETENCIES

To view more data, you need to register with us.

Existing User? Log In

Not a member yet? Join

Change Password

BOARD EVALUATION DETAILS
2025-26